Q1 2026 Holdings
Filed 2026-05-15 | 115 holdings | $318.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-06-04) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc | COM | 156944101 | $97.4M | 1,439,393 | 30.6% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $10.5M | 502,012 | 3.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $7.9M | 80,792 | 2.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $7.5M | 195,685 | 2.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $7.1M | 187,876 | 2.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $7.1M | 209,547 | 2.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $6.7M | 2,947,826 | 2.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $6.4M | 164,030 | 2.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.3M | 108,450 | 2.0% |
| Tango Therapeutics Inc | COM | 87583X110 | $6.3M | 300,648 | 2.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.8M | 149,399 | 1.8% |
| Avalo Therapeutics Inc | COM NEW | 05338F307 | $5.4M | 360,064 | 1.7% |
| Minerva Neurosciences Inc | COM NEW | 603380206 | $5.4M | 889,254 | 1.7% |
| CG Oncology Inc(CGON) | COM | 156944100 | $5.1M | 75,758 | 1.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $4.9M | 172,731 | 1.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $4.8M | 43,052 | 1.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $4.6M | 54,258 | 1.4% |
| Pharvaris N V | COM | N69605109 | $4.1M | 143,966 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.0M | 61,269 | 1.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.9M | 115,770 | 1.2% |
| Enliven Therapeutics Inc | COM | 29337E103 | $3.7M | 95,253 | 1.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.6M | 222,468 | 1.1% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $3.6M | 128,168 | 1.1% |
| Cytomx Therapeutics Inc. | COM | 23284F106 | $3.4M | 714,000 | 1.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $3.2M | 213,819 | 1.0% |
| Century Therapeutics IncA | COM | 15673T101 | $3.2M | 1,400,000 | 1.0% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $3.1M | 433,515 | 1.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.9M | 86,283 | 0.9% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.8M | 625,708 | 0.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADS | 04351P101 | $2.8M | 12,179 | 0.9% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $2.7M | 516,972 | 0.9% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $2.6M | 101,248 | 0.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.6M | 128,487 | 0.8% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.6M | 257,738 | 0.8% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $2.4M | 14,055 | 0.7% |
| Compass Therapeutics Inc | COM | 20454B105 | $2.2M | 423,566 | 0.7% |
| Dianthus Therapeutics Inc | COM | 252828109 | $2.2M | 26,551 | 0.7% |
| Eupraxia Pharmaceuticals Inc | COM | 29842P106 | $2.0M | 276,000 | 0.6% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $1.9M | 99,887 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.9M | 69,571 | 0.6% |
| Soleno Therapeutics Inc | COM | 834203310 | $1.8M | 54,000 | 0.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.8M | 3,393 | 0.6% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $1.7M | 371,398 | 0.5% |
| Leonabio Inc(LONA) | COM | 04746L203 | $1.7M | 164,676 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $1.6M | 295,688 | 0.5% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $1.6M | 379,082 | 0.5% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $1.6M | 56,147 | 0.5% |
| SAB Biotherapeutics Inc | COM NEW | 78397T203 | $1.5M | 400,000 | 0.5% |
| Minerva Neurosciences Inc(NERV) | COM NEW | 603380205 | $1.5M | 248,476 | 0.5% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $1.5M | 77,858 | 0.5% |